Increased risk of chronic kidney disease after total thyroidectomy: A nationwide matched cohort study

• Published in: The journal of clinical endocrinology and metabolism
• Main Authors: Reinke, Rasmus, Udholm, Sebastian, Christiansen, Christian Fynbo, Almquist, Martin, Londero, Stefano, Rejnmark, Lars, Rasmussen, Thomas Bøjer, Rolighed, Lars
• Format: Journal Article
• Language: English
• Published: United States 10.08.2024
• Subjects: Charlsons Comorbidity Index; Chronic Kidney Disease; Hypoparathyroidism; Total thyroidectomy; Thyrotoxicosis
• ISSN: 1945-7197
• DOI: 10.1210/clinem/dgae534

Development of hypoparathyroidism (hypoPT) after total thyroidectomy (TT) may increase the risk of kidney-related morbidity. We aimed to examine the risk of hypoPT and chronic kidney disease (CKD) in patients undergoing TT in Denmark over a 20-year period. Using population-based registries, we identified all Danish individuals with TT between January 1998 and December 2017. We included a matched comparison cohort by randomly selecting 10 citizens for each patient, by sex and birth year. We calculated cumulative incidence and hazard ratio (HR) of CKD by Cox regression in patients with TT compared with the comparison cohort. Further, CKD risks were stratified by indications for TT and comorbidity groups according to Charlson Comorbidity Index. We included 2421 patients with TT and 21.5% had hypoPT. After 10 years, the risk of developing CKD for hypoPT patients was 13.5% (95% CI:9.8-17.7), 11.6% (95% CI: 9.7-13.7) for patients without hypoPT, and 5.8% (95% CI: 5.3-6.2) for the comparison cohort. When compared with the matched comparison cohort, the adjusted HR for CKD in hypoPT patients was 3.23 (95% CI: 2.37-4-41) and 2.27 (1.87-2.75) for patients without hypoPT. For patients without previous comorbidities, the adjusted HR of CKD was higher than in patients with several comorbidities. HypoPT was a frequent complication after TT and was associated with an increased risk of CKD. We also found an increased risk of CKD in patients with a normal parathyroid function after TT, which needs to be further evaluated.